Taho Pharmaceuticals Ltd. (TPEX:6467)
133.50
0.00 (0.00%)
At close: Aug 19, 2025, 1:25 PM CST
Taho Pharmaceuticals Revenue
Taho Pharmaceuticals had revenue of 7.78M TWD in the twelve months ending June 30, 2025, down -970.13% year-over-year.
Revenue (ttm)
7.78M
Revenue Growth
-970.13%
P/S Ratio
881.94
Revenue / Employee
288.11K
Employees
27
Market Cap
6.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | 1.07M | -5.29M | -83.23% |
Dec 31, 2022 | 6.36M | -6.04M | -48.73% |
Dec 31, 2017 | 12.40M | -23.61M | -65.57% |
Dec 31, 2016 | 36.01M | 939.00K | 2.68% |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Taiwan Semiconductor Manufacturing Company | 3,401.20B |
Hon Hai Precision Industry | 7,422.86B |
MediaTek | 573.54B |
Delta Electronics | 469.36B |
Fubon Financial Holding | 814.41B |
Chunghwa Telecom | 233.45B |
Quanta Computer | 1,831.66B |
Cathay Financial Holding | 842.91B |